Rollover Study of VX-770 in Cystic Fibrosis Subjects
Clinical trial NCT01117012 · COMPLETED
Trial details
- NCT number
- NCT01117012
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.